India

Possible Game Changer: Bharat Biotech’s Nasal Vaccine Against COVID-19 Cleared For Use

By
OB Bureau

New Delhi: In a major boost to India, Bharat Biotech’s first-of-its-kind needle-free intranasal vaccine for COVID-19 received emergency use authorisation from the Drugs Controller General of India (DCGI) on Tuesday. The regulator approved the vaccine for primary immunisation of those aged 18 years and above, for restricted use in emergency situations, Union health minister Mansukh Mandaviya tweeted.

According to Bharat Biotech, its COVID-19 intranasal vaccine, BBV154, has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials phase III. The vaccine candidate was evaluated earlier in phase I and II clinical trials with successful results. Bharat Biotech chairman and managing director Krishna Ella had recently said that the firm completed clinical trials of the nasal vaccine with about 4,000 volunteers and there is no single instance of side effect or adverse reaction reported so far, News18 reported.

Bharat Biotech’s nasal vaccine uses a chimpanzee cold virus to deliver a harmless copy of the coronavirus spike protein to the lining of the nose. It has been specifically formulated to allow intranasal delivery and has been developed in partnership with Washington University St Louis, which had designed and developed the recombinant adenoviral vectored constructs and evaluated them in preclinical studies for efficacy.

The DCGI had earlier given its nod to conduct clinical trials for Bharat Biotech’s intranasal vaccine as a booster dose. The drug regulator had also permitted the firm to conduct a phase 3 clinical trial to compare the immunogenicity and safety of BBV154 (intranasal) with Covaxin.

Two separate and simultaneous clinical trials were conducted to evaluate BBV154 as a primary dose (2-dose) schedule and a heterologous booster dose for subjects who have previously received two doses of the two commonly administered COVID vaccines in India.

OB Bureau

Recent Posts

Bhubaneswar Records Longest Spell Of Temp Above 40°C In April This Season

Bhubaneswar: The Odisha capital recoded the longest spell of maximum day temperature of more than…

May 2, 2024

Riot Police Deployed At US Colleges After Violent Protests Over Gaza War

New Delhi: There was heavy police deployment on US university campuses on Wednesday after forcibly…

May 2, 2024

Former Odisha BJP Mahila Morcha President Simantini Jena Quits Party Ahead Of Elections

Bhubaneswar: Senior Bharatiya Janata Party (BJP) leader Simantini Jena resigned from the party on Thursday…

May 2, 2024

Odisha Elections 2024: Will Congress Be Able To Regain Its Lost Glory In Talsara?

Sundargarh: Talsara Assembly constituency in Odisha’s Sundargarh is likely to witness a three-way fight in…

May 2, 2024

Sex Tapes Scandal: Lookout Notice Against Prajwal Revanna Across World

New Delhi: The Special Investigation Team (SIT), probing the obscene videos case involving JD(S) Lok…

May 2, 2024

[In Pic] Naveen Patnaik Files Nomination For Kantabanji: Know Impact It Can Have On Odisha Elections

Balangir: Chief Minister and BJD president Naveen Patnaik on Thursday filed nomination for Kantabanji, the…

May 2, 2024

iPhone Users Are Getting Late To Work; Here’s The Reason

New Delhi: Apple has an unusual problem at hand. Its iPhone alarms aren't working. The…

May 2, 2024

Woman Mowed Down By Truck In Cuttack; 3 Injured As Bus From Bhubaneswar Meets With Mishap In Balasore

Cuttack: A woman was killed and her husband critically injured after a truck dashed against…

May 2, 2024